CS Paper Radar

Do AI Agents need Preventive Care? An Epidemiologic Cohort Design for Agentic AI

Shu Jiang, Graham A. Colditz

cs.AI cs.MA ·submitted 2026-11-09 22:59 UTC · v1

Abstract

As AI agents increasingly perform tasks autonomously across sectors, including healthcare and biomedical research, understanding how their behaviors develop and influence outcomes over time becomes increasingly important. Existing evaluations largely focus on model capabilities and performance on predefined tasks. Here, we propose an epidemiologic cohort design for studying agentic AI, drawing on principles established in human population studies. The framework treats individual agents as members of a cohort, their underlying model as genetic makeup, accumulated work as their time scale, and naturally occurring behaviors as exposures that may influence subsequent outcomes. By following agents longitudinally, this approach enables investigation of behavioral determinants of adverse events, estimation of their potential preventable burden under causal assumptions, and characterization of behavioral changes over an agent's work life. We illustrate the design through two prospective observational cohorts examining curiosity and probing as a safety question, and data checking and analytical accuracy as a reliability question. Together, the framework and illustrative studies provide a generalizable blueprint for designing epidemiologic cohorts of AI agents.

Closest papers

Nearest neighbours by meaning across the whole index.

The Watchtower Imperative: Lifespan-Calibrated Evaluation for Frontier AI

cs.CY cs.AIcs.HC ·2026-10-26 ·Casey M. Williams, Jennifer Victoria Scurrell
similarity 0.62
Abstract

The gap between AI capability deployment and safety assurance is structural and cannot be closed through internal evaluations alone. Analyzing documented harms (2017-2026) across the human lifespan reveals that disparate incidents --- from voice assistants endangering children to AI companions implicated in adolescent suicide and automated care denials for the elderly --- reflect a single failure: evaluating systems against an implicit adult user model. We introduce five developmental moderators structured into a Lifespan Vulnerability Matrix across six life stages. The matrix reveals a nonmonotonic risk distribution: vulnerability peaks at both ends of the lifespan, governance coverage is asymmetrical, and authority to convert model errors into real-world impact is scrutinized least. We then propose a set of lifespan design principles generalizing existing child-protective instruments, and an institution-agnostic, three-tier external evaluation framework --- comprising automated simulation, expert red teaming, and post-deployment monitoring --- indexed directly to matrix risk cells.

0.26

ComBodied Agents: a New Paradigm of Human-Centric Agentic AI

cs.AI ·2026-08-11 ·Qianggang Ding, Xingyao Wang, Rui Feng, Zhibin Wang, Feixiang Yao +17 more
benchmarkhighly cited similarity 0.61
Abstract · 38 pages, 6 figures, 10 tables

After an older adult misses a medication dose, a software agent can send another reminder and an embodied agent can bring the medication. Yet neither explains whether the person forgot, is confused, has side effects, or deliberately refused, nor what support is appropriate. This reveals a structural gap in Agentic AI: Digital Agents primarily transform software states, while Embodied Agents transform physical states; neither makes a person's evolving state and agency the primary object of modeling, intervention, and evaluation. We introduce Combodied Agents, a human-centered paradigm that perceives, models, predicts, and supports individual human-state trajectories over time, using software tools, sensors, wearables, robots, and human services as action channels rather than end goals. We unify fragmented capabilities across personal assistants, health agents, AI companions, and adaptive human--AI systems into a closed loop: event-based multimodal perception reconstructs meaningful personal events; longitudinal, correctable memory provides temporal context; Personal World Models estimate future personal states and outcomes under alternative decisions and interventions; and an admissible intervention policy selects proportionate support under consent, uncertainty, safety, reversibility, and user control. Feedback from the person and environment updates the loop. Rather than requiring an exhaustive Human Digital Twin, the framework uses purpose-bounded, uncertainty-aware, user-correctable representations. We organize the design space by human-state targets, relational contexts, and agent roles, and propose scenario-centered evaluation, agency-preservation metrics, benchmark requirements, edge-native personal models, and governance directions. Combodied Agents shift Agentic AI from external task completion toward sustained human benefit.

0.48

Examining the Vulnerability of Multi-Agent Medical Systems to Human Interventions for Clinical Reasoning

cs.AI ·2026-09-02 ·Benjamin C Liu, Dillon Mehta, Rishi Malhotra, Adam Zobian, Yong Ying Tan +5 more
similarity 0.61
Abstract

Human interventions at fault points can alter the diagnostic accuracy of multi-agent medical systems. We defined fault points as moments in AI agent conversations, in which an agent's reasoning became most vulnerable to external influence. Using the MedQA dataset, this study analyzed simulated doctor-patient conversations to measure how interventions shifted reasoning and accuracy. Correct intervention methods showed an improvement in baseline diagnostic accuracy of up to 40%, while incorrect or bias-related interventions degraded performance by up to 6% and increased diagnostic drift and uncertainty. Beyond performance changes, our analysis revealed behavioral similarities between cognitive biases in simulated agent environments and real-world clinical practice. Examples included premature closure and susceptibility to misleading cues. Overall, these findings demonstrate that identifying and guiding fault points with human interventions may provide a mechanism for improving diagnostic robustness in multi-agent medical systems.

0.28

AI Morbidity and Mortality: A Framework for Clinical AI Failure Review

cs.AI cs.HC ·2026-08-31 ·Paulius Mui, Dean F. Sittig, Steve Labkoff, Sanjay Basu
similarity 0.61
Abstract

Clinical artificial intelligence is increasingly embedded in real-world care, yet existing safety mechanisms are poorly suited to reconstructing and learning from individual AI-related errors and near-misses. Aggregate model monitoring can identify performance changes, and traditional patient safety reporting can capture adverse events, but neither is designed to explain how risk emerges across the interaction among AI systems, clinicians, workflows, and institutional controls. We propose AI Morbidity and Mortality (AI M&M), a structured, blameless framework for case-based review of clinical AI failures. The framework combines standardized case intake, evidence preservation and investigator-level reconstruction, tool-in-loop attribution, and corrective-action tracking. Each event is classified across four linked dimensions: Trigger - Mechanism - Clinical Pathway - Corrective Action, separating the condition that exposed a vulnerability from the process that produced risk, its consequence for care, and the remediation assigned. We demonstrate the framework using five illustrative outpatient medication and clinical decision-support cases; two clinician reviewers independently applied all four classification axes and reached agreement across all 20 axis-level classifications. AI M&M is intended to complement, rather than replace, model monitoring, patient safety reporting, and regulatory oversight by converting individual AI-in-workflow failures into actionable institutional learning. Prospective evaluation across institutions, AI systems, and clinical settings is needed.

0.13

LifeLong Digital Twin: A Unified Modeling Paradigm and Agent Harness for Event-Driven Lifelong Health State Trajectories

cs.AI q-bio.QM ·2026-10-04 ·Jin Jiang, Sean Yates, Jasper Chong, Raymond Brooks, Alex Lawson +2 more
similarity 0.60
Abstract · 15 pages, 5 figures, 2 tables. Technical report

Human health is a continuous, dynamic trajectory shaped by the cumulative interplay of biological processes, clinical events, behaviors and environmental exposures across the life course. Unifying the full breadth of lifelong health information, including longitudinal records, genetic variation, molecular profiles and environmental histories, is essential for whole-person modeling and remains a major challenge. We introduce LifeLong Digital Twin, a unified, event-driven modeling paradigm that organizes Life Events into daily Health States and accumulates them into Lifelong Health Context. An accompanying Agent Harness incorporates multimodal evidence beyond the language model's textual context. We evaluate four language models across 25 disease endpoints on three tasks: Disease Trajectory Forecasting, Disease Risk Ranking and Multi-horizon Disease Prediction. The approach yields marked gains over the reference condition: model-averaged F1 increases by 22.0% for disease identification in trajectory forecasting and 18.3% for five-year disease outcomes; thyroid-disease F1 reaches 0.669. The framework provides a foundation for whole-person digital twins and research on personalized lifelong disease prevention.

0.20

Can AI Agents Interface Clinicians and Complex Models?

cs.MA cs.AI ·2026-10-29 ·Giulio Colombini, Matteo Falcioni, Mario Massimo, Francesco Durazzi, Marianna Santoro +3 more
similarity 0.60
Abstract · 21 pages, 7 figures

Background: Contemporary healthcare institutions generate daily very large amounts of data, which contain highly useful information for the improvement of work organization, planning and overall efficiency. While models and techniques to extract these insights are well known and constantly developed in mathematical biology, complex systems physics and data science, the adoption of these techniques among Clinicians and Hospital Administrators remains limited, mainly due to language and methodological divides. Objective: In this article we implement an AI Multi Agent System (MAS) that allows Users to use predictive models and make statistical analyses via natural language conversations. Methods: We developed EpidemIA, a training-free MAS endowed with a modular suite of epidemiological models written by human experts, executable on a single-GPU workstation. To avoid relaying sensitive data to third parties, the system uses locally an open-weights LLM as backbone for its two subagents. Results: Using a dataset of Emergency Department visits provided to us by IRCCS Sant'Orsola (Bologna) we test the model on a few typical use cases, demonstrating the possibility of performing both simpler statistical analyses and visualizations as well as more complicated epidemiological predictions based on dynamical models, through simple queries made in natural language. Conclusions: While still being a proof-of-concept implementation, EpidemIA showcases the transformative capabilities of LLM based technologies as an enabling factor in the widespread adoption of complex dynamical models, which is at present hindered by their steep learning curve.

0.14

VITAL: A Framework for Validating Agentic AI in Pharmaceutical Drug Development and Clinical Trial Operations

cs.AI ·2026-11-17 ·Sandeep Burugupalli, Pedro Matos-Filipe, Andrea Hita Ardiaca, Adam Taylor, Alex Grigorenko +8 more
similarity 0.60
Abstract

Current assurance approaches do not establish whether evidence is sufficient to validate, monitor and govern agentic artificial intelligence (AI) within a pharmaceutical context of use. Plausible outputs may conceal failures in retrieval, reasoning, orchestration or human-control points, where reference standards are unavailable. We developed and operationalised VITAL (Validation by Intended use, Traceability, Autonomy and Lifecycle evidence), a validation framework for agents in clinical development, through landscape analysis, regulatory and standards mapping, expert interviews and multi-stakeholder refinement. VITAL integrates context of use, controls, behavioural validation and lifecycle evidence within a risk-adjusted framework. We applied VITAL across epidemiology and treatment-landscape analysis, site selection, enrolment rescue and trial-design trade-off support to translate autonomy, reversibility, transparency and patient impact into proportionate validation activities, evidence requirements and auditable reconstruction of system behaviour. VITAL may inform evidence requirements and lifecycle accountability for higher-risk pharmaceutical uses; evaluation should assess reproducibility across assessors, organisations and system configurations.

0.25

A Sociotechnical Review of Algorithms in Health Systems: Technical, Cost, and Human-Centered Considerations

cs.HC ·2026-09-18 ·Victoria Chui, Kelly McConvey, Shion Guha
similarity 0.60
Abstract

Artificial intelligence (AI) applications in healthcare are becoming increasingly prevalent, to assist health systems, providers, and patients with tasks such as decision-making, risk prediction, and diagnosis. This increasing computational potential brings AI applications to the forefront of workplace decision making, often without full consideration of subsequent computational, organizational, and social costs. These applications are leveraged to reduce healthcare costs and increase efficiency of daily tasks, with model-related costs being considered at varying levels of granularity. To understand these trends, we critically analyze 114 papers to examine how cost-aware AI models have been developed for health systems. We explore the data, method, and outcome choices of these models, as well as their intersection with cost and human-centered concerns, highlighting the gaps in rigorous sociotechnical model design. From these trends, we define model costs and subsequent dimensions, presenting insight into those studies reporting financial, computational, organizational and/or social measures. Further, we critique the benefits and challenges of evaluating model-related costs and sustainability concerns when developing AI models for health systems.

0.23